Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Med.

Sec. Geriatric Medicine

Intranasal insulin and postoperative delirium in adult surgical patients: A meta-analysis and systematic review of randomized controlled trials

Provisionally accepted
Li-cai  ZhangLi-cai ZhangJianli  SongJianli SongLi-quan  QiuLi-quan QiuQiang  LiQiang LiXuan  YuXuan YuBin  LuBin Lu*Guanyu  ChenGuanyu Chen*
  • Zigong Fourth People's Hospital, Zigong, China

The final, formatted version of the article will be published soon.

Abstract Introduction: The efficacy and safety of intranasal insulin (INI) for preventing postoperative delirium (POD) remain uncertain. Methods: We searched PubMed, Web of Science, Cochrane Library, Embase, and registers from inception to July 1, 2025, for randomized controlled trials (RCTs) enrolling adult surgical patients that compared INI with control (saline) investigating the efficacy of INI for POD prevention. The risk of bias was assessed using the revised Cochrane Risk of Bias tool (RoB 2), and the certainty of evidence was evaluated with the GRADE framework. Primary and secondary outcomes were POD incidence and a comprehensive set of secondary measures (including cognitive scores, hypoglycemia rates, pain scores, and inflammatory markers), respectively. Results: A meta-analysis of 7 randomized trials (n=765) showed that INI significantly reduced the incidence of POD within 3 days postoperatively (RR = 0.35; 95% CI: 0.26-0.46; P < 0.001; I ² = 0%) and improved cognitive recovery (MMSE mean difference = 0.99; 95% CI: 0.52-1.47; P < 0.001; I² = 1.7%). INI also reduced early postoperative interleukin-6 (IL-6) levels without affecting the incidence of hypoglycemia or pain scores. Conclusion: INI may protect perioperative cognitive function, reduce POD incidence within 3 days postoperatively, and alleviate postoperative inflammation without increasing hypoglycemia risk. However, larger-scale, randomized, multicenter trials are needed to confirm clinical efficacy and establish optimal protocols. Trial registration: The protocol for this meta-analysis is available in PROSPERO (CRD42024614995)

Keywords: Meta-analysis, postoperative delirium, Systematic review, Intranasal insulin, Hypoglycemia

Received: 09 Aug 2025; Accepted: 24 Oct 2025.

Copyright: © 2025 Zhang, Song, Qiu, Li, Yu, Lu and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Bin Lu, adghkl123456@163.com
Guanyu Chen, 741755319@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.